Table 2 Participant Characteristics and Descriptive Statistics of Additional Outcomes
Characteristic | Participants (N = 111) |
|---|---|
Age, mean (SD), years | 44.37 (15.2) |
Median, minimum–maximum | 41.0, 22–82 |
Sex, n (%) | |
Male | 24 (21.6) |
Female | 87 (78.4) |
Race and ethnicity, n (%) | |
White | 67 (60.4) |
African American | 28 (25.2) |
Asian | 3 (2.7) |
American Indian or Pacific Islander | 0 (0.0) |
Other | 1 (0.9) |
Hispanic | 12 (10.8) |
Symptoms experienced at day 1 due to RSV, n (%) (per screening) | |
Cough | 76 (68.5) |
Cough with mucous | 56 (50.5) |
Stuffy nose | 58 (52.3) |
Runny nose | 50 (45.0) |
Sore throat | 35 (31.5) |
Body aches or pain | 42 (37.8) |
Shortness of breath | 44 (39.6) |
Fatigue | 63 (56.8) |
Sinus pain | 28 (25.2) |
Ear pain | 20 (18.0) |
Headache | 49 (44.1) |
Wheezing | 32 (28.8) |
Loss of appetite | 38 (34.2) |
PGIS at day 1, mean (SD) median | 2.47 (0.8) 2.0 |
1 = None | 9 (8.1) |
2 = Mild | 51 (45.9) |
3 = Moderate | 41 (36.9) |
4 = Severe | 10 (9.0) |
PGIS at day 2, mean (SD), median | 2.26 (0.7) 2.0 |
1 = None | 12 (12.6) |
2 = Mild | 51 (53.7) |
3 = Moderate | 27 (28.4) |
4 = Severe | 5 (5.3) |
Missing | 16 (14.4) |
PGIC at day 2, mean (SD) median | 2.28 (0.9) 2.0 |
1 = Much better | 20 (21.1) |
2 = A little better | 37 (38.9) |
3 = No change | 30 (31.6) |
4 = A little worse | 7 (7.4) |
5 = Much worse | 1 (1.1) |
Missing | 16 (14.4) |
SDS Work/School, mean (SD) at day 1 | 4.95 (3.2) |
Median, minimum–maximum | 5.0, 0–10 |
SDS Family Life/Home Responsibilities, mean (SD) at day 1 | 5.08 (3.1) |
Median, minimum–maximum | 5.0, 0–10 |